Spotlight on canine CRP testing - Gentian at AAVLD 2025

20. Oct 2025 | 4 min read

Spotlight on canine CRP testing - Gentian at AAVLD 2025

Meet Gentian to discuss CRP testing in dogs

Gentian Diagnostics looks forward to connecting with veterinary professionals, laboratory leaders, and diagnostic experts at AAVLD 2025 - American Association of Veterinary Laboratory Diagnosticians November 1st-2nd. Our team will be at booth # 326 to discuss how the Gentian Canine CRP Immunoassay can help expand your diagnostic capabilities and support improved canine care. 

 canine crp blood test - gentian

 

Why canine CRP matters in veterinary diagnostics 

Veterinary laboratories across the US and internationally are increasingly integrating CRP into their routine testing menus as awareness of its diagnostic value grows.

Key clinical applications – from diagnosis to monitoring: 

  • Systemic inflammation marker: To diagnose infection or inflammatory disorders  
  • Early diagnosis of infection: Clinically significant levels as early as 4-6 hours after onset  
  • Reflects the degree of inflammation: Tool for surveillance of disease activity   
  • Monitoring of treatment efficacy: Effective treatment reduces CRP rapidly (short half-life)  
  • Prognostic assessment: In cases of increased risk of infection, such as post operation 

 New call-to-action

 

The Gentian Canine CRP Immunoassay: Easy to implement in routine lab workflows 

Gentian’s Canine CRP Immunoassay is designed to make this important biomarker accessible and reliable for veterinary labs: 

  • Produced with canine-specific antibodies for consistent accuracy  
  • Wide measuring range up to 300 mg/L, supporting use in both acute and chronic cases  
  • Validated across a broad range of clinical chemistry analyzers, enabling flexible integration  
  • Short lead time - shipped from the US  

Instrument-independent, cost-efficient,  
and easy to implement in routine lab workflows 

 

New call-to-action

 

 

Get in touch  

 

You may also read


Cystatin C, GFR and Shrunken Pore Syndrome: Insights from Dr. A. Grubb

Jan 20, 2026

Cystatin C, GFR and Shrunken Pore Syndrome: Insights from Dr. A. Grubb

Expanding the understanding of kidney disease Shrunken Pore Syndrome (SPS) and Selective Glomerular..

GCAL® Calprotectin - From insights to impact - January 2026

Jan 13, 2026

GCAL® Calprotectin - From insights to impact - January 2026

Continuing the GCAL® journey: Building on 2025, moving into 2026 Over the past year, interest in circulating..

Meet Gentian Diagnostics in 2026 - Conferences & Exhibitions

Jan 07, 2026

Meet Gentian Diagnostics in 2026 - Conferences & Exhibitions

Meet us at conferences in 2026 We will be attending a range of conferences and exhibitions throughout 2026...